ocrevus - ocrelizumab injection
(Ocrelizumab)Genentech, Inc.
Usage: Ocrevus treats relapsing forms of MS (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) and primary progressive MS in adults.
Antibodies, Monoclonal, Humanized [CS] class drugs
6 results
ocrevus zunovo - ocrelizumab and hyaluronidase injection, solution
(Ocrelizumab And Hyaluronidase)Genentech, Inc.praxbind - idarucizumab injection
(Idarucizumab)Boehringer Ingelheim Pharmaceuticals, Inc.tecentriq - atezolizumab injection, solution
(Atezolizumab)Genentech, Inc.Usage: Tecentriq is a PD-L1 blocking antibody indicated for non-small cell lung cancer (adjuvant and metastatic), extensive-stage small cell lung cancer, unresectable or metastatic hepatocellular carcinoma, BRAF V600 mutation-positive melanoma, and alveolar soft part sarcoma in adults and pediatric patients 2 years and older.tecentriq hybreza
(Atezolizumab And Hyaluronidase-Tqjs)Genentech, Inc.trogarzo - ibalizumab injection, solution
(Ibalizumab)Theratechnologies Inc.Usage: Trogarzo, combined with other antiretrovirals, treats HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 who are failing their current antiretroviral regimen.